Harano M[au] - Search Results

Year	Number of Results
1955	1
1956	1
1967	1
1971	1
1973	2
1974	1
1975	1
1993	1
1994	1
1996	2
1997	2
1998	4
1999	9
2000	7
2002	1
2003	1
2004	13
2005	14
2006	14
2007	8
2008	18
2009	7
2010	5
2011	3
2012	1
2013	2
2014	7
2015	3
2016	7
2017	5
2019	8
2020	8
2021	4

1

[Microsatellite Instability in Gastric Cancer].

Choda Y, Kubota T, Ishida M, Sato D, Yoshimitsu M, Nakano K, Harano M, Matsukawa H, Idani H, Shiozaki S, Okajima M. Choda Y, et al. Among authors: harano m. Gan To Kagaku Ryoho. 2019 Dec;46(13):1914-1916. Gan To Kagaku Ryoho. 2019. PMID: 32157011 Japanese.

2

Hiatal Hernia.

Castelijns B, Ponten JE, Van de Poll MC, Nienhuijs SW, Smulders JF, Hu ZW, Wu JM, Wang ZG, Idani H, Asami S, Nakano K, Miyake S, Harano M, Miyoshi H, Araki H, Ogawa T, Takahashi K, Shiozaki S, Ninomiya M, Prasad A, Todkar J, Asti E, Lovece A, Sironi A, Bonavina L, Wright R, Wurst H, Zhang C, Li HL, Ke LM, Loi K, Hua R, Yao QY, Chen H, Okinyi W, Odende K, Ndungu B, Ndonga A, Kiragu P, Kelimu A, Alimujiang M, Tian W, Bing M. Castelijns B, et al. Among authors: harano m. Hernia. 2015 Apr;19 Suppl 1:S13-7. doi: 10.1007/BF03355320. Hernia. 2015. PMID: 26518789 No abstract available.

3

[Outcome of Repeated Surgical Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer].

Oshita K, Yoshimitsu M, Imaoka K, Yano T, Satoh D, Fujiwara T, Nakano K, Harano M, Matsukawa H, Idani H, Matsuura M, Shiozaki S, Okajima M. Oshita K, et al. Among authors: harano m. Gan To Kagaku Ryoho. 2020 Aug;47(8):1271-1273. Gan To Kagaku Ryoho. 2020. PMID: 32829372 Japanese.

4

Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M. Shiota M, et al. Among authors: harano m. Anticancer Res. 2020 Jan;40(1):335-339. doi: 10.21873/anticanres.13957. Anticancer Res. 2020. PMID: 31892584 Clinical Trial.

5

Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M. Shiota M, et al. Among authors: harano m. Cancer Chemother Pharmacol. 2019 Sep;84(3):561-566. doi: 10.1007/s00280-019-03874-7. Epub 2019 May 21. Cancer Chemother Pharmacol. 2019. PMID: 31115605

6

[Effect on Prognosis of Immune-Related Adverse Events after Nivolumab Treatment in Gastric Cancer].

Kubota T, Choda Y, Ishida M, Yano T, Sato D, Yoshimitsu M, Nakano K, Harano M, Matsukawa H, Idani H, Shiozaki S, Okajima M. Kubota T, et al. Among authors: harano m. Gan To Kagaku Ryoho. 2020 Dec;47(13):1860-1862. Gan To Kagaku Ryoho. 2020. PMID: 33468853 Japanese.

7

Therapeutic Outcome of >10 Cycles of Cabazitaxel for Castration-resistant Prostate Cancer: A Multi-institutional Study.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M. Shiota M, et al. Among authors: harano m. Anticancer Res. 2019 Aug;39(8):4411-4414. doi: 10.21873/anticanres.13612. Anticancer Res. 2019. PMID: 31366538 Clinical Trial.

8

Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study.

Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M. Shiota M, et al. Among authors: harano m. Anticancer Drugs. 2020 Mar;31(3):298-303. doi: 10.1097/CAD.0000000000000884. Anticancer Drugs. 2020. PMID: 31913197

9

[Total Pelvic Exenteration and Perineal Reconstruction with a Gracilis Myocutaneous Flap for Local Recurrence of Rectal Cancer].

Yunoki K, Yoshimitsu M, Oshita K, Yano T, Kubota T, Ishida M, Sato D, Choda Y, Nakano K, Harano M, Matsukawa H, Idani H, Shiozaki S, Okajima M. Yunoki K, et al. Among authors: harano m. Gan To Kagaku Ryoho. 2020 Dec;47(13):2349-2351. Gan To Kagaku Ryoho. 2020. PMID: 33468957 Japanese.

10

[A Case of Gastric Cancer with Continued Progression-Free Survival Even after Total Gastrectomy and Nivolumab Therapy].

Fujii H, Choda Y, Kubota T, Ishida M, Sato D, Sumitani D, Yoshimitsu M, Nakano K, Harano M, Matsukawa H, Idani H, Shiozaki S, Okajima M. Fujii H, et al. Among authors: harano m. Gan To Kagaku Ryoho. 2019 Dec;46(13):2318-2320. Gan To Kagaku Ryoho. 2019. PMID: 32156917 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results